Van Bael & Bellis

­Congratulations to Turpaz Industries Ltd. (TASE: TRPZ)— a global leader in the development, production, and marketing of flavour extracts and unique raw materials which acquired 100% of the share capital of Doucy, a market leader sweet flavours manufacturer in Belgium 🍭 It was a real pleasure for VBB to assist in this successful transaction 👏 Our M&A team consisted of partner Caroline DAOUT, counsel Virginie Lescot and associate Viktor Francq #successfulacquisition #mergersandacquisitions #turpazindustries #doucy

Proud Platinum Sponsor of the The John H. Jackson Moot Court Competition ⚖️ VBB is honoured to continue its longstanding role as the Platinum Sponsor of the 23rd edition of the John H. Jackson Moot Court Competition, a premier event dedicated to helping shape the next generation of trade law professionals. This global competition challenges law students to engage with complex international trade law and WTO dispute settlement issues, developing their oral and written advocacy and critical reasoning skills. With the largest trade team in Brussels and a dedicated WTO practice, we are committed to supporting initiatives that foster talent and excellence in international trade law. We look forward to seeing this year’s participants showcase their expertise on the global stage 🤩 More info here: https://lnkd.in/dcqTYruT #JHJacksonMoot #WTO #TradeLaw #FaceTheGlobalChallenge

Congratulations to our client Swissgrid AG on its successful appeal before the Court of Justice of the European Union of its exclusion from European electricity balancing platforms.   Our team was led by partners Philippe De Baere and Peter L’Ecluse and comprised counsel Valérie Lefever and Koen T'Syen as well as associate Victor Ion.   Read more here ➡️ https://lnkd.in/dAapcDBr

The European Commission has released the findings of its first-ever investigation under the International Procurement Instrument (IPI), focusing on China’s public procurement market for medical devices. The results? Unsurprisingly, the Commission concluded that EU medical device makers do not have fair access to procurement processes in China. This could pave the way for IPI measures, potentially restricting the access of Chinese medical device operators or products to the EU’s public procurement or concession markets. What does this mean for the future of global procurement? Read our team’s breakdown ➡️ https://lnkd.in/dpf6V8Yt Andreas Reindl | Jorren Garrez #EUCommission #MedicalDevices #Procurement #IPI

In the wake of restrictive trade measures announced by the US President Donald Trump, an important question on everyone’s mind is how the EU will respond to those measures. Many have argued for the recourse to the Anti-Coercion Instrument (ACI), a relatively new and very powerful tool in the EU’s arsenal. The ACI entered into force on 27 December 2023 and has never been used so far. Is that about to change? Our latest client alert explains what the ACI is, how it operates and whether it can be deployed vis-à-vis the US. See it here: https://lnkd.in/gH2wZwJ2 Joanna Redelbach | Lea Leonhardt #anticoercioninstrument #trademeasures

Earlier this week, our colleagues represented VBB at the inaugural Women & Law Empowerment Group (WLEG) breakfast in Brussels, hosted by Legal Diversity & Inclusion Alliance. The discussion covered key challenges women face in the legal profession, from career development to mentorship, gender equality at partner level, and fair allocation of work. This meeting is just the beginning 💪 We look forward to continuing the conversation and working towards concrete solutions for increasing gender equality in the legal field ♀️ #WomenInLaw #DiversityAndInclusion #LegalProfession 

On 13 February 2025, the Rotterdam Court confirmed the ACM’s fine on Leadiant for excessive pricing, with only a minor reduction to €17.03M due to the case’s duration. More on the topic here: https://lnkd.in/dGsCxagR Michael Clancy | Peter L'Ecluse | Catherine Longeval | Koen T'Syen

Last week, the Swiss medicines agency, Swissmedic, and the Swiss Association of Research Ethics Committees, Swissethics, issued an updated version of their position paper on decentralised #ClinicalTrials with medicinal products (DCTs). Read more from our team of #LifeSciences experts: https://lnkd.in/dQynxVGa Michael Clancy | Peter L'Ecluse | Catherine Longeval | Koen T'Syen

Updates on the EU’s 16th Sanctions Package 🔎 As discussions within the Council of the EU continue, details of the anticipated 16th #sanctions package are gradually emerging. The European Commission circulated its proposal in early February, and so far, it appears to be facing minimal opposition from EU Member States. Our latest client alert below highlights the most notable new #trade restrictions expected in this latest package ⬇️ https://lnkd.in/dNEbyuG3 Fabrizio Di Gianni | Michelle Linderman | Aldo Scalini | Emily Greenaway #EUSanctions #TradeCompliance #Geopolitics

VBB’s eco-friendly ski trip 🎿🌍 Last week, our annual ski trip took us to the stunning Dolomites—this time by sleeper train, in line with the firm’s green goals for 2025! Despite a classic Belgian train delay, the journey through the Netherlands, Germany, and Austria made for a scenic adventure that no level of photography could fully capture. Between skiing, hiking and unwinding in the spa, the experience was unforgettable. The perfect send-off before the journey back to Brussels? Fresh snowfall on our final morning! A huge thanks to the organisers, and we look forward to next year! ❄️🏔️ #SkiTrip2025 #GreenTravel #LawFirmLife #Dolomites